Top 15 Health Care VC Funds in Iceland
A list of 15 VC funds that invest in Health care startups based in Iceland. We rank investors based on the number of investments they made in Health care companies from Iceland. We update this investor list every month.Top 15 Health Care VC Funds in Iceland
Investor | Health Care Iceland investments |
---|---|
New Business Venture Fund | 9 |
Novator | 3 |
Frumtak Ventures | 3 |
Iceland Venture Studio | 2 |
Brunnur Ventures | 2 |
Silicon Valley Bank | 2 |
Flerie Invest | 1 |
Crowberry Capital | 1 |
Wellington Partners | 1 |
ABC Ventures | 1 |
Asabys Partners | 1 |
Probiocon | 1 |
Kvika Asset Management | 1 |
Baliopharm | 1 |
Silfurberg | 1 |
The New Business Venture Fund is an evergreen investment fund that actively contributes to the development and growth of the Icelandic economy by investing in promising innovation and start-up companies.The New Business Venture Fund invests at seed and early stage in promising growth companies with great business ideas and strong management anddevelopment teams.The New Business Venture Fund is a state owned investment fund intended to strengthen and develop the Icelandic venture capital market along with promoting startups and business in Iceland thus encouraging economic growth.
Show more
Investment focus
- Software, Health Care, Medical
- Seed, Funding Round, Series A
- Iceland, United States, China
Portfolio highlights
- HorseDay — HorseDay is a mobile application to track horse activities.
- Spectaflow — Spectaflow is a SaaS solution for accommodations businesses focused on improving housekeeping and maintenance workflows
- PayAnalytics — PayAnalytics, a leading pay equity and workforce analytics solution, aids companies in closing pay gaps and fostering workplace equity. Ensure compliance with pay transparency regulations, assess wage disparities, and analyze workforce demographics conveniently.
Novator is an alternative investment firm founded and led by the international investor and entrepreneur Thor Bjorgolfsson.Novator's investment portfolio is focused around following sectors: Telecommunications, Pharmaceuticals, IT and Renewable Energy. In addition, Novator operates a Private Equity Fund and a Credit Opportunities Fund.Novator focuses on developing strong management teams in each of its portfolio companies. While granting them the autonomy to create value, Novator maintains a supervisory role, principally through representation on the Boards of its investee companies. Novator differentiates itself from many other private equity companies in concentrating on complex situations, either by virtue of their structure or their cross-border nature. To create value, Novator undertakes the restructuring or "de-risking" of investment opportunities through re-financing, combining acquired assets with existing businesses, through sale to strategic or financial buyers, or through flotation. Novator's investment portfolio is focused around four main sectors:Telecommunications, Pharmaceuticals, IT and Renewable Energy.
Show more
Investment focus
- Information Technology, Software, E-Commerce
- Funding Round, Series A, Series B
- United Kingdom, Iceland, Germany
Portfolio highlights
- Olive — Olive's technology evaluation platform finds & compares your best-match enterprise software & manages the selection process. Build requirements from pre-built libraries. Compare all solutions in the market against your unique business needs. Olive takes the best practices of digital transformation and shortens the process allowing you to make smart decisions, faster.
- Klang Games — Klang Games is an entertainment & game development studio in Berlin, developing the MMO Simulation and Virtual World, Seed. Klang is always hiring!
- Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
Frumtak (a.k.a. Frumtak Investment Fund, Frumtak I, Frumtak 1) was founded December 23rd. 2008. The objective was to invest in early stage growth companies that were post seed and had growth potential. This would result in leading companies that could deliver a good return to investors.At the close of Frumtak‘s investment period on December 31st.2012, the fund had invested in fifteen companies with nine investments still active. The remainder of lifetime of the fund is used to follow on investments and divest assets.Frumtak Ventures (Frumtak II, Frumtak 2) started in February 2015. The fund builds on the legacy of Frumtak 1. The fund invests in early stage innovative companies that are post seed and show great potential for growth. The fund invests primarily in Iceland but is allowed to invest abroad as allowed by law in connection with its portfolio investments to ensure success in foreign markets.Frumtak II emphasizes to invest in companies where growth and sales in foreign markets are the primary objective, but does not specialize in any particular industry. The fund wants to ensure that original ideas get a chance and thereby increasing the probability of creating growth and value. By doing this, it enforces the image that Icelandic innovation is profitable.Frumtak II aspires to be a trusted and popular ally. The fund strives to have a good relationship and co-operation with all stakeholders within the start-up and innovation community. The fund puts a special emphasis on co-operating with stakeholders outside Iceland.
Show more
Investment focus
- Software, Information Technology, Enterprise Software
- Seed, Funding Round, Series A
- Iceland, United States, United Kingdom
Portfolio highlights
- 50skills — Bring people, information and tools together. 50skills is a hiring system and so much more.
- Spectaflow — Spectaflow is a SaaS solution for accommodations businesses focused on improving housekeeping and maintenance workflows
- Abler — Abler brings simplicity to the complexities of team management. With easy scheduling, messaging, payment, and data tools, Abler empowers users to spend more time cultivating the essential life skills and values learned through sports and other organised activities.
We help people grow and build decentralized companies
Show more
Investment focus
- Health Care, Software, B2B
- Seed, Pre-Seed, Funding Round
- Iceland, India, Israel
Portfolio highlights
- Soptle — Founded in Sep 2021, Soptle started to establish an integrated technology to the neglected regional FMCG Manufacturers in India with a B2B Retail Commmerce App. It uses tech and data to distribute at scale and use necessary components (existing Distributor/Wholesaler) in the FMCG Supply Chain to build a high growth and profitable business.
- Expertrons — Expertrons is an upskilling platform that offers advanced training programs | BSFI | HR | Marketing and many more to assure 100% professional success.
- Nanom — Greenvolt Nano creates nano-enhanced materials for use in battery technology. It provides a pathway to clean, inexpensive, and renewable energy sources while reducing environmental toxicity. And makes products smarter, efficient, and longer lasting. It is founded in 2017.
Brunnur Ventures is a top venture capital firm in Iceland for startups with high-growth potential.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Series A, Angel
- Iceland, United States, Denmark
Portfolio highlights
- PaxFlow — PaxFlow is a travel technology startup that helps tour operators to streamline operations with resource management, data based workflows, customer communication and self service tools.
- Vitar Games — A WW1 Strategy driven Management Game
- Standby Deposits — Standby Deposits is a rental security deposit replacement based on credit.
Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Debt Financing, Series B, Series A
- United States, United Kingdom, Canada
Portfolio highlights
- Carputty — Carputty is a superior way to finance a car. Buying new, used, or refinancing? Carputty's flexible line of credit simplifies the process. Get started now!
- Coast — Coast is the simple, all-in-one fleet and fuel card that helps businesses easily pay for and track vehicle expenses. It's quick to set up, easy-to-use, and full of rewards.
- HawkEye 360 — HawkEye 360 is a space-based RF data analytics company with one-of-a-kind solutions to better spectrum mapping and monitoring on land & water
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Sweden, Israel, Iceland
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
- Software, Gaming, Health Care
- Seed, Series A, Pre-Seed
- Iceland, Denmark, Finland
Portfolio highlights
- Saidot — Saidot is a governance tool for safe, ethical and transparent AI.
- Rocky Road — At Rocky Road, we are redefining social gaming with our social gaming network. We are hiring!
- Scaleup Finance — Improve your financial management
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Germany, United States, United Kingdom
Portfolio highlights
- Nosto — Smarter commerce experience management with AI-fueled personalization, merchandising, and site search
- Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
- Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
ABC Ventures operates as an investment firm.
Show more
Investment focus
- Water, Medical, Health Care
- Pre-Seed, Series A
- India, Iceland
Portfolio highlights
- Polka Pop — Polka Pop is India's first brand to serve naturally flavored sparkling water with zero calories and no added sugar. Supporting a sustainable lifestyle choice, this healthy drink is available in four flavors, i.e. lemon-lime, orange, peach, and cranberry. The fizz makes this the best mix for cocktails and mocktails.
- EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Series A, Seed, Series B
- Spain, Belgium, Germany
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.
Probiocon is a consulting company offering comprehensive services for pharmaceutical and biotechnological companies. We give advice and support for all kind of corporate development activities (services) needed for biotech and pharma companies, including but not limited to Corporate Financing, Licensing & Partnering, Merger & Acquisition,and Corporate Organisation.Their vision is to provide optimized and cost-effective solutions to the special needs of companies developing biopharmaceutical compounds.
Show more
Investment focus
- Medical, Consulting, Health Care
- Seed
- Iceland
Portfolio highlights
- 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
Kvika Asset Management manages a broad range of funds including equity funds, bond funds and mixed funds.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A
- Iceland
Portfolio highlights
- EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.
Show more
Investment focus
- Medical, Consulting, Health Care
- Seed
- Iceland
Portfolio highlights
- 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies. The firm follows up its investments as an active participant in the company and aims all the time to add value to its investments whenever possible. Silfurberg was founded in 2002 and is based in Reykjavík,Iceland.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A
- Iceland
Portfolio highlights
- Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Medical
Real Estate
Email
Wellness
Social Media
Music
Franchise
Celebrity
Infrastructure
Android
Internet
Legal
Google
Big Data
eSports
Organic Food
Construction
Local
Photography
Mobile
Enterprise Software
Sports
Social Network
Fashion
Manufacturing
Education
Digital Media
Facebook
B2B
Art
Renewable Energy
Social Impact
Payments
Financial Services
Recruiting
Sporting Goods
Platforms
Travel
Fitness
Finance
Mobile Advertising
Retail
Automotive
Cannabis
Crowdfunding
Biotechnology
Hospitality
CleanTech
Transportation
Wine And Spirits
Mobile Apps
InsurTech
Medical Device
Enterprise
Social
SaaS
LGBT
Film
Life Science
Theatre
Non Profit
Software
Cryptocurrency
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Finland
Estonia
Kuwait
Faroe Islands
Greece
Israel
Ethiopia
Jersey
Ghana
Kazakhstan
Nicaragua
Philippines
Hungary
Croatia
Italy
Mali
Lithuania
Cambodia
Egypt
Liechtenstein
Kenya
Belgium
Liberia
Lebanon
Mauritius
Barbados
Morocco
Ecuador
Malaysia
France
Norway
Hong Kong
Peru
Seychelles
Myanmar
Cayman Islands
Panama
Slovenia
Malta
Mexico
Russian Federation
Rwanda
Nigeria
Serbia
Uzbekistan
Togo
Bahamas
Taiwan
Azerbaijan
Iraq
Iceland
Ukraine
Namibia
United Arab Emirates
Sierra Leone
Turkey
Honduras
Tunisia
Thailand
Isle of Man
Bolivia
Tajikistan
Poland
Luxembourg
Uganda
Zimbabwe
Tanzania
Pakistan
San Marino
Uruguay
Albania
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Argentina
Bangladesh
Grenada
Jordan
Romania
Sweden
Austria
El Salvador
Switzerland
Cyprus
Latvia
Oman
Colombia
Guatemala
Marshall Islands
VC Funds in Iceland by industry
Media (entertainment)
Manufacturing
Financial Services
Climate
Marketplace
Education
Payments
Food and Beverage
Video Games
Medical
Medical Device
Internet
Android
Mobile
Software
Enterprise Software
FinTech
Platforms
Biotechnology
Enterprise
Health Care
EdTech
SaaS
Community
Artificial intelligence
Hardware
Gaming
Sports
Biotech